Gilead Sciences stock pre-market at EUR 135.08: plus 1.08 percent versus the Xetra close

Published on 10/12/2026 at 08:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Gilead Sciences was at EUR 135.08 in pre-market trading at Lang & Schwarz on October 12, 2026, up 1.08 percent versus the October 9 Xetra close. Its 52-week high was EUR 136.24.

Key points in brief

Gilead Sciences was at EUR 135.08 in pre-market trading at Lang & Schwarz on October 12, 2026.
The stock was 1.08 percent above the Xetra close of October 9, 2026, at EUR 133.64.
The cited 52-week high was EUR 136.24, while the reported P/E was minus 56.62.

Flatlay mit Aktienzertifikat ISIN US3755581036 Gilead Sciences Labormaterialien auf Marmor — Gilead Sciences Flatlay ISIN US3755581036 Aktienzertifikat ISIN-Karte Ampullen Molekülmodell Stethoskop weißer Marmor, Illustration mit AI erstellt.

Gilead Sciences stock was at EUR 135.08 in pre-market trading at Lang & Schwarz at 8:30 a.m. CEST on October 12, 2026. The price was EUR 1.44, or 1.08 percent, above the Xetra close of October 9, 2026, at EUR 133.64.

Pre-market trading

Lang & Schwarz showed a bid of EUR 134.82 and an ask of EUR 135.34. The quote was recorded before the Xetra session opened at 9:00 a.m. CEST. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Gilead Sciences stock.

What matters today

The home-market date in focus is October 12, 2026, for Gilead Sciences' Nasdaq listing. The cited 52-week high is EUR 136.24, which is 0.86 percent above the Lang & Schwarz price. The reported P/E was minus 56.62 as of October 9, 2026.

Trading range and valuation

The quoted 52-week range extended from EUR 98.96 to EUR 136.24. The reported dividend yield was 2.00 percent as of October 9, 2026. The EUR 135.08 pre-market price was EUR 1.16 below the cited 52-week high and EUR 36.12 above the cited 52-week low.

Market context: Market report S&P 500.

More news and analysis on Gilead Sciences stock